Texas Childrens Hospital

The trials here

What the 17 trials at this site are about, from their registry records.

Conditions

• Childhood cancers6 trials
• Neuroblastoma2 trials
• Obesity2 trials
• Obstructive sleep apnoea2 trials
• Type 2 diabetes2 trials
• Acute lymphoblastic leukaemia1 trial
• ANCA-associated vasculitis1 trial
• Cerebral palsy1 trial
• Colorectal cancer1 trial
• Dystonia1 trial
• Epilepsy1 trial
• Glioblastoma1 trial
• and 9 more

Phase

• Phase 35 trials
• Phase 12 trials
• Phase 22 trials
• Early phase 11 trial
• Phase 1/21 trial
• Phase 41 trial

Status

• Active, not recruiting6 trials
• Completed5 trials
• Not yet recruiting3 trials
• Recruiting3 trials

Lead sponsor

• Eli Lilly and Company6 trials
• Baylor College of Medicine4 trials
• Novartis Pharmaceuticals2 trials
• Amgen1 trial
• Incyte Corporation1 trial
• and 3 more

Running trials

• Recruiting

  Efficacy, Safety, and Pharmacokinetics of Tirzepatide (LY3298176) Once Weekly Versus Placebo in Pediatric Participants 6 to Less Than 12 Years of Age Who Have Obesity (ADVANCE-SURMOUNT-KIDS)

  NCT07817875· Phase 3· Eli Lilly and Company· Source

  Contact: Stephanie Sisley (principal investigator)

• Recruiting

  A Study of Dulaglutide (LY2189265) 3.0 mg and 4.5 mg in Pediatric Participants With Type 2 Diabetes Mellitus (AWARD-PEDS PLUS)

  NCT06739122· Phase 3· Eli Lilly and Company· Source

  Contact: Siripoom McKay (principal investigator)

• Recruiting

  A Platform Trial for Pediatric Participants With Obesity or Overweight (LY900040)

  NCT06672549· Phase 3· Eli Lilly and Company· Source

  Contact: Stephanie Sisley (principal investigator)

• Recruiting

  Intrathecal Baclofen and Pediatric Dystonia

  NCT06606574· Baylor College of Medicine· Source

  Contact: Principal Investigator, MD, PhD

• Active, not recruiting

  Study to Evaluate Avacopan in Combination With a Rituximab or Cyclophosphamide-containing Regimen, in Children From 6 Years to < 18 Years of Age With AAV.

  NCT06321601· Phase 3· Amgen· Source

• Active, not recruiting

  A Study of LY3295668 Erbumine in Participants With Relapsed/Refractory Neuroblastoma

  NCT04106219· Phase 1· Eli Lilly and Company· Source

• Recruiting

  A Master Protocol (LY900023) That Includes Several Clinical Trials of Drugs for Children and Young Adults With Cancer

  NCT05999994· Phase 2· Eli Lilly and Company· Source

  Contact: Jodi Muscal (principal investigator)

• Active, not recruiting

  Pediatric Long-Term Follow-up and Rollover Study

  NCT03975829· Phase 4· Novartis Pharmaceuticals· Source

• Recruiting

  Fetal Endotracheal Occlusion (FETO) in the Resolution of Pulmonary Hypertension in Fetuses With Severe CDH

  NCT03980717· Michael A Belfort· Source

  Contact: Michael Belfort, M.D.

• Active, not recruiting

  A Study of Oral LOXO-292 (Selpercatinib) in Pediatric Participants With Advanced Solid or Primary Central Nervous System (CNS) Tumors

  NCT03899792· Phase 1/2· Eli Lilly and Company· Source

• Active, not recruiting

  Roll-over Study to Collect and Assess Long-term Safety of Everolimus in Patients With TSC and Refractory Seizures Who Have Completed the EXIST-3 Study [CRAD001M2304] and Who Are Benefitting From Continued Treatment

  NCT02962414· Phase 3· Novartis Pharmaceuticals· Source

• Active, not recruiting

  Autologous/Allogeneic TGFbeta-resistant LMP-specific CTL, Lymphoma (TGF-beta)

  NCT00368082· Phase 1· Baylor College of Medicine· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Obesity2 recruiting
• Cerebral palsy1 recruiting
• Childhood cancers1 recruiting
• Dystonia1 recruiting
• High blood pressure1 recruiting
• Pulmonary arterial hypertension1 recruiting
• Type 2 diabetes1 recruiting

Closed trials

• Completed

  Safety Evaluation of MiniMed™ 780G System With DS5 CGM in Children

  NCT06604871· Medtronic MiniMed, Inc.· Source

• Completed

  Identification of Oxygen Desaturation in Patients Admitted Following Adenotonsillectomy'

  NCT06512285· Baylor College of Medicine· Source

• Completed

  iotaSOFT Pediatric Study

  NCT06106373· iotaMotion, Inc.· Source

• Completed

  Effect of Opioids on Central Control of Ventilation in Children With Obstructive Sleep Apnea

  NCT05051189· Early phase 1· Baylor College of Medicine· Source

• Completed

  A Phase 2 Study of Ruxolitinib With Chemotherapy in Children With Acute Lymphoblastic Leukemia

  NCT02723994· Phase 2· Incyte Corporation· Source